BioAgilytix Appoints Dave Beyerlein to Global Lead for LC/MS Amid Continued Expansion

Durham, NC – [June 25, 2025] – BioAgilytix, a global leader in bioanalytical services, announces the appointment of Dave Beyerlein as Global Lead for Liquid Chromatography–Mass Spectrometry (LC/MS) Platforms. In this role, Beyerlein will lead BioAgilytix’s strategic growth into new markets while ensuring scientific excellence and consistency globally for LC/MS operations.   

With over 25 years at BioAgilytix, Beyerlein is a recognized authority in mass spectrometry and bioanalytical strategy. In his new global role, he will lead the standardization and ongoing innovation of LC/MS capabilities across BioAgilytix’s laboratories in Durham, NC; San Diego, CA; Hamburg, DE; and Melbourne, AU—ensuring scientific rigor and operational excellence at every stage of drug development. BioAgilytix has been a leader in LC/MS for more than two decades and is home to one of the largest LC/MS-focused bioanalytical labs on the West Coast. 

“Dave’s deep expertise, long-standing commitment to BioAgilytix, and passion for quality science make him the ideal leader for our global LC/MS platform,” said Davide Molho, CEO of BioAgilytix. “As we continue expanding our international presence to meet growing demand, his leadership will help ensure the consistency and quality that our partners expect.” 

BioAgilytix’s LC/MS teams operate as a globally integrated network, sharing best practices and operating under unified Standard Operating Procedures that align with global regulatory frameworks. This structure enables seamless method transfers, accelerated development timelines, and consistently high-quality data—delivered locally and globally across all phases of development. 

“LC/MS plays a central role in supporting the next generation of biotherapeutics, and I’m honored to lead this platform globally,” said Dave Beyerlein, Global Lead for LC/MS and General Manager of the San Diego Lab. “With continued investment in people, platforms, and geographic reach, we’re well-positioned to support our partners wherever innovation takes them.” 

As part of BioAgilytix’s Global Leads initiative, Beyerlein will collaborate with the Scientific Office, Operations, and Commercial teams to guide scientific innovation, proposal development, and platform training across regions. 

Learn more about BioAgilytix’s LC/MS capabilities here.

About BioAgilytix

BioAgilytix is the trusted partner for bioanalytical services throughout every phase of the drug development process. As a leading global bioanalytical laboratory, the company provides established and emerging pharmaceutical and biotechnology organizations with pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services in a GxP environment. BioAgilytix maintains state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany. For more information, please visit www.bioagilytix.com. 

For more information, please contact:

Noelle Brawner
Communications Manager
BioAgilytix Labs, LLC
Noelle.brawner@bioagilytix.com